Skip to content

Clinical trials

Completed Dyslipidemias trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Completed Country / region: Canada Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20042
20053
20062
20073
20083
20091
20102
20117
20124
20133
20142
20151
20161
20174
20182
20192
20202
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Akcea Therapeutics3
Bristol-Myers Squibb3
Pfizer3
AstraZeneca2
Kastle Therapeutics, LLC2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Queen's University2
Sanofi2
University Health Network, Toronto2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias54
Hyperlipidemias12
Cardiovascular Diseases9
Hypercholesterolemia9
Hypertension9
Obesity9
Lipid Metabolism Disorders8
Metabolic Diseases8
Diabetes Mellitus7
Hyperlipoproteinemias7

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.